Hospital-Associated Multicenter Outbreak of Emerging Fungus Candida auris, Colombia, 2016.
Adolescent
Adult
Aged
Aged, 80 and over
Antifungal Agents
/ pharmacology
Candida
/ drug effects
Candidemia
/ epidemiology
Candidiasis
/ drug therapy
Child
Child, Preschool
Colombia
/ epidemiology
Communicable Diseases, Emerging
/ epidemiology
Cross Infection
Disease Outbreaks
Drug Resistance, Fungal
Female
History, 21st Century
Humans
Infant
Male
Microbial Sensitivity Tests
Middle Aged
Mortality
Patient Outcome Assessment
Public Health Surveillance
Seasons
Young Adult
Candida auris
Colombia
antimicrobial resistance
candidemia
fungi
healthcare-associated
nosocomial infections
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
entrez:
19
6
2019
pubmed:
19
6
2019
medline:
24
12
2019
Statut:
ppublish
Résumé
Candida auris is an emerging multidrug-resistant fungus that causes hospital-associated outbreaks of invasive infections with high death rates. During 2015-2016, health authorities in Colombia detected an outbreak of C. auris. We conducted an investigation to characterize the epidemiology, transmission mechanisms, and reservoirs of this organism. We investigated 4 hospitals with confirmed cases of C. auris candidemia in 3 cities in Colombia. We abstracted medical records and collected swabs from contemporaneously hospitalized patients to assess for skin colonization. We identified 40 cases; median patient age was 23 years (IQR 4 months-56 years). Twelve (30%) patients were <1 year of age, and 24 (60%) were male. The 30-day mortality was 43%. Cases clustered in time and location; axilla and groin were the most commonly colonized sites. Temporal and spatial clustering of cases and skin colonization suggest person-to-person transmission of C. auris. These cases highlight the importance of adherence to infection control recommendations.
Identifiants
pubmed: 31211679
doi: 10.3201/eid2507.180491
pmc: PMC6590770
doi:
Substances chimiques
Antifungal Agents
0
Types de publication
Historical Article
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Références
Emerg Infect Dis. 2013 Oct;19(10):1670-3
pubmed: 24048006
Clin Infect Dis. 2017 Jan 15;64(2):134-140
pubmed: 27988485
Eur J Pediatr. 2010 Jul;169(7):783-7
pubmed: 19957192
Emerg Infect Dis. 2017 Jan;23(1):162-164
pubmed: 27983941
Rev Iberoam Micol. 2017 Jan - Mar;34(1):23-27
pubmed: 28131716
BMC Infect Dis. 2016 Aug 20;16(1):433
pubmed: 27544427
Emerg Infect Dis. 2014 Jul;20(7):1250-1
pubmed: 24963796
N Engl J Med. 2015 Oct 8;373(15):1445-56
pubmed: 26444731
Intensive Care Med. 2014 Sep;40(9):1303-12
pubmed: 25097069
J Clin Microbiol. 2017 Oct;55(10):2996-3005
pubmed: 28747370
Clin Infect Dis. 2019 Jan 1;68(1):15-21
pubmed: 29788045
J Clin Microbiol. 2012 Nov;50(11):3641-51
pubmed: 22952266
Clin Infect Dis. 2016 Feb 15;62(4):409-17
pubmed: 26810419
Am J Transplant. 2017 Jan;17(1):296-299
pubmed: 28029734
Med Intensiva. 2016 Apr;40(3):139-44
pubmed: 26725105
Clin Infect Dis. 2012 Nov 15;55(10):1352-61
pubmed: 22893576
Eur J Clin Microbiol Infect Dis. 2014 Jun;33(6):919-26
pubmed: 24357342
J Infect. 2016 Oct;73(4):369-74
pubmed: 27452195